GAVI faces US funding cuts, risking millions of kids missing vaccines. It’s the global health org boosting immunization in poor countries.
WomenX Biotech in Hong Kong developed a menstrual blood HPV test, but the government dismissed it citing insufficient evidence. The company remains optimistic, planning further communication with authorities despite product delisting. The story highlights tensions between innovation and regulation in health tech.